Hepatocellular cancer therapy in patients with HIV infection: Disparities in cancer care, trials enrolment, and cancer-related research

by Francesca Negri, Gabriele Missale, Anna Degli Antoni, Camillo Porta
Published 2021-09-01

PREGNANCY LOSS IN WOMEN WITH HIV IS NOT ASSOCIATED WITH HIV MARKERS: DATA FROM A NATIONAL STUDY IN ITALY, 2001-2018

by Marco Floridia, Giulia Masuelli, Beatrice Tassis, Enrica Tamburrini, Valeria Savasi, Matilde Sansone, Arsenio Spinillo, Giuseppina Liuzzi, Anna Degli Antoni, Serena Dalzero, Laura Franceschetti, Giuliana Simonazzi, Gianpaolo Maso, Daniela Francisci, Carmela Pinnetti, Marina Ravizza
Published 2019-08-01

A prospective randomized trial on abacavir/lamivudine plus darunavir/ritonavir or raltegravir in HIV-positive drug-naïve patients with CD4<200 cells/uL (the PRADAR study).

by Cristina Mussini, Enrica Roncaglia, Vanni Borghi, Stefano Rusconi, Silvia Nozza, Anna Maria Cattelan, Daniela Segala, Paolo Bonfanti, Antonio Di Biagio, Enrico Barchi, Emanuele Focà, Anna Degli Antoni, Stefano Bonora, Daniela Francisci, Silvia Limonta, Andrea Antinori, Gabriella D'Ettorre, Franco Maggiolo
Published 2019-01-01

Reduced mortality in COVID-19 patients treated with colchicine: Results from a retrospective, observational study.

by Lucio Manenti, Umberto Maggiore, Enrico Fiaccadori, Tiziana Meschi, Anna Degli Antoni, Antonio Nouvenne, Andrea Ticinesi, Nicoletta Cerundolo, Beatrice Prati, Marco Delsante, Ilaria Gandoflini, Lorenzo Donghi, Micaela Gentile, Maria Teresa Farina, Vincenzo Oliva, Cristina Zambrano, Giuseppe Regolisti, Alessandra Palmisano, Caterina Caminiti, Enrico Cocchi, Carlo Ferrari, Leonardo V Riella, Paolo Cravedi, Licia Peruzzi
Published 2021-01-01